TP53 and cancer: Preclinical studies have demonstrated its apoptotic-inducing effect in various types of cancers and different associated molecular mechanisms, like IκBα nuclear retention, NF-κB signaling inhibition, and survivin transcriptional inhibition3,25; nuclear accumulation of p53 and FOXO3a26.